gacyclidine has been researched along with aptiganel in 1 studies
| Studies (gacyclidine) | Trials (gacyclidine) | Recent Studies (post-2010) (gacyclidine) | Studies (aptiganel) | Trials (aptiganel) | Recent Studies (post-2010) (aptiganel) |
|---|---|---|---|---|---|
| 36 | 1 | 2 | 45 | 7 | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnaud, S; D'Arbigny, P; Feldblum, S; Rabin, O; Simon, M | 1 |
1 other study(ies) available for gacyclidine and aptiganel
| Article | Year |
|---|---|
Efficacy of a new neuroprotective agent, gacyclidine, in a model of rat spinal cord injury.
Topics: Animals; Astrocytes; Cyclohexanes; Cyclohexenes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Female; Gliosis; Guanidines; Neuroprotective Agents; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Recovery of Function; Spinal Cord; Spinal Cord Injuries; Stereoisomerism | 2000 |